METHODS OF USING THIAZOLIDINE DERIVATIVES TO TREAT CANCER OR INFLAMMATION

Details for Australian Patent Application No. 2003223805 (hide)

Owner KINETEK PHARMACEUTICALS, INC.

Inventors ZHANG, Zaihui; DAYNARD, Timothy, S.; KALMAR, Gabriel, Bela

Pub. Number AU-A-2003223805

PCT Number PCT/CA03/00682

PCT Pub. Number WO2003/094916

Priority 60/379,929 10.05.02 US

Filing date 8 May 2003

Wipo publication date 11 November 2003

International Classifications

A61K 031/426 - 1,3-Thiazoles

A61K 031/427 - not condensed and containing further heterocyclic rings

A61P 035/00 Antineoplastic agents

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/379,929 10.05.02 US

15 January 2004 Application Open to Public Inspection

  Published as AU-A-2003223805

27 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

19 November 2009 Corrigenda

  Applications OPI - Name Index Under the name Qlt Inc., Application No. 2003223805, under INID (43) correct the publication date to read 24.11.2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003223806-Process for hydrogenating unactivated imines using ruthenium complexes as catalysts

2003223804-ELECTRODE CATALYST FOR H2S FUEL CELL